出版國(guó)家:United States
出版周期:雙月刊
影響因子:0.333
研究領(lǐng)域:雜交瘤細(xì)胞
5年影響因子:0.373
國(guó)外數(shù)據(jù)庫(kù)收錄:IM,0.333" />
Monoclonal Antibodies in Immunodiagnosis and Immunotherapy(formerly Hybridoma), presents the latest developments in characterization and application of mAbs and publishes descriptions and resources of novel mAbs. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy’s targeted coverage advances our understanding of immune responses and is an essential resource on the use of immunological methods for experimental and therapeutic purposes for researchers and clinicians in immunology and cancer biology.
Fully refereed, peer-reviewed articles and short communications present current findings in the development and characterization of mAbs across all therapeutic areas. Development of mAbs for all research applications, including probes, inhibitors, and diagnostic reagents, is also described.